These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE. Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075 [Abstract] [Full Text] [Related]
8. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Sud A, Hui JM, Farrell GC, Bandara P, Kench JG, Fung C, Lin R, Samarasinghe D, Liddle C, McCaughan GW, George J. Hepatology; 2004 May; 39(5):1239-47. PubMed ID: 15122752 [Abstract] [Full Text] [Related]
10. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. Sebastiani G, Vario A, Guido M, Alberti A. J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453 [Abstract] [Full Text] [Related]
11. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group. Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837 [Abstract] [Full Text] [Related]
12. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C. Said Y, Salem M, Mouelhi L, Mekki H, Houissa F, Ben Rejeb M, Moussa A, Trabelsi S, Debbeche R, Bouzaidi S, Najjar T. Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964 [Abstract] [Full Text] [Related]
13. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z. Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611 [Abstract] [Full Text] [Related]
14. Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index. Resino S, Micheloud D, Miralles P, Bellón JM, Vargas A, Catalán P, Alvarez E, Cosín J, Lorente R, López JC, Muñoz-Fernández MA, Berenguer J. HIV Med; 2010 Jan; 11(1):64-73. PubMed ID: 19686437 [Abstract] [Full Text] [Related]
18. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease]. Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH. Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264 [Abstract] [Full Text] [Related]
19. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T, MULTIVIRC Group. Groupe d'Etude Multidisciplinaire sur les Pathologies Liées au Virus C. Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267 [Abstract] [Full Text] [Related]
20. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP. J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]